ArticleFrontiers in psychology2025
HDRPS+: a new affective pictorial scale applicable to organizational contexts.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Repeatedly capturing individuals' emotions is challenging in organizational settings, especially for low-literacy groups, and existing pictorial scales cover arousal only narrowly. We therefore developed the Highly Dynamic and Reusable Picture-based Scale Plus (HDRPS+), an optimized successor to HDRPS that measures valence and arousal simultaneously. Methods: Three sub-studies were conducted. (1) Picture pool construction: 20 thematic images were created to span the affective space. (2) Picture screening: crowdsourced ratings anchored each image's valence -arousal coordinates. (3) Validation: a 7-day diary study with 442 participants (age 13-69, M = 27.06) tested reliability and validity. Results: HDRPS+ achieved good user retention, with 80.3 % of participants providing data on at least five days. It also showed acceptable stability (consistency = 0.69 valence, 0.65 arousal) without materially influencing the affect it is intended to measure. Correlations with the Self-Assessment Manikin (SAM) confirmed concurrent validity (r = 0.63 for valence; 0.52 for arousal), while all coefficients with PANAS were < 0.45, supporting discriminant validity. Participants judged the scale accurate or very accurate in 78 % of cases, and indirect checks (vs. SAM) indicated reduced social_desirability bias. Discussion: HDRPS+ is low_cost, quick, and well_tolerated, enabling continuous affect tracking in diverse organizational settings. Future work should keep refining emotional granularity, broaden application formats, and test cross_cultural use. HDRPS+ images with normative scores are available at https://osf.io/d4wcn.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.